Interlaboratory method validation of HPLC-FMA for determination of polysorbate 80 in monoclonal antibodies
10.16438/j.0513-4870.2021-0151
- VernacularTitle:HPLC-FMA法测定单抗药物中聚山梨酯80含量的方法学联合验证
- Author:
Xiao-juan YU
;
Chuan-fei YU
;
Rong-jian ZHANG
;
Gang WU
;
Yong-fei CUI
;
Lu-yun GUO
;
Lan WANG
- Publication Type:Research Article
- Keywords:
polysorbate 80;
HPLC-FMA;
method validation;
monoclonal antibody
- From:
Acta Pharmaceutica Sinica
2021;56(8):2276-2281
- CountryChina
- Language:Chinese
-
Abstract:
The high performance liquid chromatography-fluorescence micelle assay (HPLC-FMA) method for the content determination of polysorbate 80 in monoclonal antibody drugs was validated to study its applicability and transferability between various laboratories, and the feasibility to be included in the Chinese Pharmacopoeia. Both J.T. Baker and Nanjing Well-sourced polysorbate 80 was used in the collaborative validation of polysorbate 80 content analysis in seven different laboratories. The results show that when the protein concentration was no more than 20 mg·mL-1 and the concentration of polysorbate 80 ranged from 0.05 to 0.5 mg·mL-1, the method had good specificity. The recovery rates of the spiked samples ranged from 92.20% to 117.70% for J.T.Baker and from 93.90% to 117.20% for Nanjing Well. The intra-laboratory precision (%RSD) was less than 4.30% for J.T. Baker, and less than 2.60% for Nanjing Well, while the overall precision was less than 5.45% for J.T. Baker, and less than 6.70% for Nanjing Well. The linear correlation coefficient was more than 0.98 for J.T. Baker and more than 0.99 for Nanjing Well. The results of the collaborative validation prove that the HPLC-FMA method has good accuracy, precision, linearity, and specificity, and could be used for release control analysis of polysorbate 80 content in monoclonal antibodies across different laboratories.
